Fundraising FoxThomas H. Lee Partners
also invests · investor profileLincoln, US · 3 known investors
Find your way into Thomas H. Lee Partners
Sign up to see every warm intro you have to Thomas H. Lee Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Thomas H. Lee Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Celerion provides clinical pharmacology and bioanalytical services to support pharmaceutical and biotechnology companies in early-phase drug development and regulatory submissions. The company operates clinical research units and bioanalytical laboratories across North America and Europe.
Founders & leadership
ST
Susan ThorntonFounder and Chief Executive Officer
Investors · 3
Frequently asked questions
- What does Thomas H. Lee Partners do?
- Celerion provides clinical pharmacology and bioanalytical services to support pharmaceutical and biotechnology companies in early-phase drug development and regulatory submissions. The company operates clinical research units and bioanalytical laboratories across North America and Europe.
- Who founded Thomas H. Lee Partners?
- Thomas H. Lee Partners was founded by Susan Thornton.
- Who are Thomas H. Lee Partners's investors?
- Thomas H. Lee Partners's investors include BCI, Kensington Capital Partners Limited, Alaska Permanent Fund Corporation.
- Where is Thomas H. Lee Partners headquartered?
- Thomas H. Lee Partners is headquartered in Lincoln, US.